Fresh2 Group Limited

Fresh2 Group Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Lishui, Zhejiang and currently employs 75 full-time employees. The company went IPO on 2020-01-30. Fresh2 Group Ltd, formerly AnPac Bio-Medical Science Co Ltd, is a holding company mainly engaged in early cancer screening and detection. The firm is engaged in marketing and selling multi-cancer screening and detection test that uses cancer differentiation analysis (CDA), technology and its cancer-detection device or CDA device. The firm's CDA technology also assists physicians in cancer diagnosis, prognosis and recurrence. The firm provides a platform on which it has developed cancer screening and detection test using its CDA technology, or CDA test, and its CDA device. Its CDA technology focuses on biophysical properties in human blood. The firm is also engaged in providing technical solution and outsourcing consulting service focusing on the digital, Internet, and Web3 transformation of start-ups and traditional enterprises.